Stay updated with breaking news from Event Reporting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vivek Subbiah, MD, emphasizes the need for improved guidance on practical toxicity management for various FGFR-altered malignancies, highlights best practices for monitoring and managing the most common on-target toxicities associated with FGFR inhibitors, and discusses the key implications of this review for those utilizing FGFR inhibitors.
The agency is advising the public, including healthcare providers, of the possible risks that products containing live bacteria or yeast, which are commonly called probiotics, pose to preterm infants in hospital settings.
FDA has posted a formal warning today about the use of probiotics with preterm infants. The notice went up after a second warning letter was sent to a company marketing a probiotic product for that use.
In May 2023, the SEC adopted amendments to Form PF, which change certain existing questions and create new events-based reporting requirements.